Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.
Genetic diversity of viral isolates in human immunodeficiency virus (HIV)-infected individuals varies substantially. However, it remains unclear whether HIV-related disease progresses more rapidly in patients harboring virus swarms with low or high diversity and, in the same context, whether high or...
Main Authors: | Joos, B, Trkola, A, Fischer, M, Kuster, H, Rusert, P, Leemann, C, Böni, J, Oxenius, A, Price, D, Phillips, R, Wong, J, Hirschel, B, Weber, R, Günthard, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
by: Fagard, C, et al.
Published: (2003) -
Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.
by: Oxenius, A, et al.
Published: (2002) -
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
by: Oxenius, A, et al.
Published: (2002) -
Supervised Treatment Interruptions Fail to Control HIV-1 Viremia.
Published: (2004-11-01) -
Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
by: Hadega A Aamer, et al.
Published: (2020-08-01)